Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Fluocinolone acetonide 0.025% gel
1304000N0AABDBD
|
Fluocinolone acetonide | Fluocinolone acetonide | Skin | 3,684 |
|
Benzalkonium chloride 0.5% shampoo
1309000L0AAABAB
|
Benzalkonium chloride (Scalp) | Benzalkonium chloride | Skin | 3,620 |
|
Doublebase emollient bath additive
1302011M0BKAAAI
|
Doublebase | Liquid paraffin | Skin | 3,572 |
|
E45 emollient wash cream
1302011L0BJAAAG
|
E45 | Light liquid paraffin | Skin | 3,570 |
|
Balneum 84.75% bath oil
130201100BBAEAA
|
Proprietary compound preparation BNF 1302011 | Emollient bath and shower preparations | Skin | 3,546 |
|
Aveeno Daily moisturising lotion
130201000BBLJA0
|
Proprietary compound emollients | Other emollient preparations | Skin | 3,528 |
|
Silkis ointment
1305020W0BBAAAA
|
Silkis | Calcitriol | Skin | 3,497 |
|
Coal tar 4% shampoo
1309000C0AABCBC
|
Coal tar (Scalp) | Coal tar | Skin | 3,479 |
|
Salactol paint
1307000M0BPAAAW
|
Salactol | Salicylic acid | Skin | 3,473 |
|
Cetraben emollient 82.8% bath additive
1302011L0BFAAAE
|
Cetraben | Light liquid paraffin | Skin | 3,456 |
|
Betamethasone dipropionate 0.05% scalp lotion
1304000D0AABCBC
|
Betamethasone esters | Betamethasone esters | Skin | 3,447 |
|
Finacea 15% gel
1306010B0BCAAAB
|
Finacea | Azelaic acid | Skin | 3,428 |
|
Cetaphil moisturising lotion
1311030A0BGAEA0
|
Cetaphil | Alkyl sulphate | Skin | 3,326 |
|
Hirudoid 0.3% gel
1314000H0BBABAB
|
Hirudoid | Heparinoid | Skin | 3,293 |
|
Locoid 0.1% Lipocream
1304000W0BBABAA
|
Locoid | Hydrocortisone butyrate | Skin | 3,195 |
|
Eucerin UreaRepair Plus 10% urea lotion
130201000BBMIDR
|
Proprietary compound emollients | Other emollient preparations | Skin | 3,174 |
|
Selenium sulfide 2.5% shampoo
1309000S0AAABAB
|
Selenium sulfide | Selenium sulfide | Skin | 3,140 |
|
Aveeno moisturising creamy oil
130201000BBLDA0
|
Proprietary compound emollients | Other emollient preparations | Skin | 3,096 |
|
Fucidin 20mg/g ointment
1310012Q0BBAAAA
|
Fucidin (Topical Ointment) | Sodium fusidate | Skin | 3,065 |
|
Hydrogen peroxide 1% cream
1310050H0AAAAAA
|
Hydrogen peroxide (Minor Cuts & Abrasions) | Hydrogen peroxide | Skin | 3,049 |
|
Vagisil 2% medicated cream
1303000N0BDAAAB
|
Vagisil | Lidocaine | Skin | 2,977 |
|
Aldara 5% cream 250mg sachets
1307000V0BBAAAA
|
Aldara | Imiquimod | Skin | 2,947 |
|
Elocon 0.1% scalp lotion
1304000Y0BBACBB
|
Elocon | Mometasone furoate | Skin | 2,943 |
|
E45 emollient bath oil
130201100BBAAAE
|
Proprietary compound preparation BNF 1302011 | Emollient bath and shower preparations | Skin | 2,919 |
|
Hydrocortisone 0.1% cream
1304000V0AAAWAW
|
Hydrocortisone (Topical) | Hydrocortisone | Skin | 2,898 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.